IGF2 and capillary hemangioma: Indeed, differences in the expression of genomic biomarkers have been reported in infantile hemangioma; e.g., insulin-like growth factor 2 (IGF-2) was found as highly expressed in proliferative lesions compared to involuting lesions [9].